Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page

Home > Publications > Research Monographs >    

Assessing Neurotoxicity of Drugs of Abuse

NIDA Research Monograph, Number 136 [Printed in 1993]

Get Adobe Reader

This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph136.pdf - Assessing Neurotoxicity of Drugs of Abuse (1.8 MB)

Table of Contents

Lynda Erinoff

Neurobehavioral Methods Used in Neurotoxicology-----1
Hugh A. Tilson

Behavioral Consequences of Partial Monoamine Depletion in the CNS After Methamphetamine-Like Drugs: The Conflict Between Pharmacology and Toxicology-----34
Lewis S. Seiden, William L. Woolverton, Stanley A. Lorens, Joseph E.G. Williams, Rebecca L. Corwin, Norio Hata, Mary Olimski

Strategies for Detecting Subclinical Monoamine Depletions in Humans-----53
Una D. McCann and George A. Ricaurte

Sensory Evoked Potentials: Measures of Neurotoxicity-----63
William K. Boyes

Silver Staining as a Tool for Neurotoxic Assessment-----101
Carlos A. Beltramino, José de Olmos, Ferenc Gallyas, Lennart Heimer, and Lászó Záborszky

Mapping Toxicant-Induced Nervous System Damage With a Cupric Silver Stain: A Quantitative Analysis of Neural Degeneration Induced by 3,4-Methylenedioxymethamphetamine-----133
Karl F. Jensen, Jeanene Olin, Najwa Haykal-Coates, James O'Callaghan, Diane B. Miller, and José S. de Olmos

Reactions of 5-HT Neurons to Drugs of Abuse: Neurotoxicity and Plasticity-----155
Mary Ann Wilson, Laura A. Mamounas, Kenneth H. Fasman, Karen J. Axt, and Mark E. Molliver

Quantification of Reactive Gliosis as an Approach to Neurotoxicity Assessment-----188
James P. O'Callaghan and Diane B. Miller

Pharmacokinetic Approaches to the Study of Drug Action and Toxicity-----213
Arthur K. Cho, Masayuki Hiramatsu, Yoshito Kumagai, and Nita Patel

Mechanisms Mediating Biogenic Amine Deficits Induced by Amphetamine and Its Congeners-----226
James W. Gibb, Michel Johnson, Donna M. Stone, and Glen R. Hanson

Neurotoxicity and Drugs of Abuse: Cannabinoid Interaction With Brain Glucocorticoid Receptors-----242
Philip W. Landfield and J. Charles Eldridge

Nitric Oxide as a Mediator of Neurotoxicity-----253
Ted M. Dawson, Valina L. Dawson, and Solomon H. Snyder

List of NIDA Research Monographs-----274

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal